Approval · Notice of Compliance 29553 · 2022
AROVYN: Notice of Compliance 29553
Issued November 28, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29553
- Date
- November 28, 2022
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- DRAXXIN (Zoetis Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AROVYN | 02532859 | Approved |
Medicinal ingredients
- TULATHROMYCIN 100 MG per ML